Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

New hope for Parkinson’s and neurodegenerative disorders: discovery of a neuroprotective peptide

Published on: 24/12/2016 Reading time: 1 min
Nouvel espoir Parkinson et maladie neurodégénératives

Researchers from the “Experimental therapeutics of neurodegeneration” team led by Etienne Hirsch at the Brain and Spine Institute – Institut du Cerveau - ICM, Institut du Cerveau et de la Moelle épinière – and collaborators, have just published a work that represents a real jump forward in the fight against neurodegenerative diseases. This work published in Nature Communications – October 21, 2014 – evidences a small peptide of viral origin which seems to protect Parkinson’s disease affected neurons against degeneration. These major advances appear very promising for the development of future therapeutic applications in the prevention of Parkinson’s disease and more broadly, of neurodegenerative diseases.

Neurodegeneration at cell level:
The progressive loss of structure and function of neurons in neurodegenerative diseases, including Parkinson’s disease, involves mitochondrial dysfunction and early axonal degeneration prior to death of cell body – axons being neurons extensions leading the electric signal from cell body toward synaptic areas. Mitochondria – the powerhouse of the cells – are small organelles (about 1 micrometer) inside cells, essential in cellular energy production and whose physiological role is crucial. When mitochondria are impaired, degeneration and progressive loss of axons is observed with a subsequent neuronal death. Consequently, agents that protect mitochondria have strong therapeutic potential.

 

Clever viruses that hijack cellular functions with maintaining host cell alive:
Different viruses and other pathogens are known to hijack cellular pathways to their advantage in order to survive and replicate in their host. A case in point is Borna disease virus (BDV), a neurotropic virus that infects nerve cells and persists in nerve tissue without damaging cells. Survival and replication of BDV in neurons depends in part on a viral protein – the X protein – that it produces and that accumulates in mitochondria where it exerts an anti-apoptotic effect(cell death inhibition), ensuring the maintenance of BDV habitat.
In view of this background, in collaboration with the team of Daniel Gonzalez-Dunia at the Purpan Physiopathology Center of Toulouse (CPTP) * and of Jean-Michel Peyrin at the Institut de Biologie Paris Seine**, Stéphane Hunot and Yann Monnet from Etienne Hirsch’s team at the Institut du Cerveau - ICM, were tempted to investigate whether the X protein could protect neurons against neurodegenerative insults.

 

Mitochondrie – organlelle des cellules – centrales énergétiques des cellules © INSERM/Torpier, Gérard
Mitochondia – cell organel – the powerhouse of the cells © INSERM/Torpier, Gérard

Research advances

Diversion of natural strategy used by BDV virus – X peptide:
Authors show that, alone, outside of the viral context, the BDV X protein has strong protective properties for axons through a mitochondrial maintaining mechanism, thereby protecting neurons from degeneration. Neuro-protective effect of this protein was validated both in vitro tissue culture and in an animal model of Parkinson’s disease. Intracranial injection of a lentiviral vector driving the expression of the BDV X, markedly reduced axonal damage and neuronal loss of dopaminergic neurons – lesion of which is involved in Parkinson’s disease. Even more interesting, these neuro-protective effects – currently tested in mice – also operate via intranasal administration of a cell-permeable peptide derived from the X protein which passes through cell membranes and localizes to mitochondria. This relatively minimally invasive method holds great promise for future therapeutics.

The identification of this neuro-protective peptide and the very promising study results of which he has been the subject, open the way to novel therapies for neurodegenerative diseases, such as Parkinson’s or Alzheimer’s, by targeting mitochondrial dynamics and thus preventing the earliest steps of neurodegenerative processes in axons.

L’administration intranasale du Peptide X protège contre la neurodégénérescence dans un modèle animal de la maladie de Parkinson © Yann Monnet/Marion Szelechowski – Nature Communications
X Peptide intranasal administration protects from neurodegeneration in a Parkinson animal model &copy Yann Monnet/Marion Szelechowski – Nature Communications

Collaborators :

* Centre de Physiopathologie de Toulouse Purpan (CPTP), INSERM UMR 1043, CNRS UMR 5282, Université Toulouse III Paul Sabatier.
** Biological Adaptation an Ageing, CNRS UMR 8256, Institut de Biologie Paris Seine, Sorbonne Universités, UPMC.

Sources

A viral peptide that targuets mitochondria protects against neuronal degenereation in models of Parkinson’s disease, Szelechowski et al., Nature Communication (online publication 21 October 2014)

Our news on the subject

Le développement du cerveau a une part d’aléatoire
The stochastic aspect of brain development
Although every person’s personality is the result of genetic and environmental factors, these are not the only factors at play. Bassem Hassan and his team at Paris Brain Institute have discovered that, in fruit flies (drosophila), individuality also...
05.12.2025 Research, science & health
Analyse MERSCOPE
New treatment pathways for brain malformation-linked focal epilepsy?
A study by Stéphanie Baulac’s team has revealed somatic mutations in different cell types in patients with type 2 focal cortical dysplasia. This disease causes drug-resistant epileptic seizures, for which the main treatment option is currently...
05.12.2025 Research, science & health
Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
La huntingtine est une protéine indispensable au développement embryonnaire, à la formation et au maintien du tissu cérébral.
Huntington's Disease: The Energy Hypothesis Gets Traction
Huntington's disease, a rare hereditary neurological disorder, is associated with an energy deficit that precedes the onset of symptoms and is closely linked to their progression. At Paris Brain Institute, Fanny Mochel and her colleagues are testing...
02.11.2025 Research, science & health
À la recherche de marqueurs d’imagerie dans la démence frontotemporale
Searching for Imaging Markers in Frontotemporal Dementia
Could exploring the relationships between different brain networks help us understand frontotemporal dementia (FTD)? This neurodegenerative disease, which progresses at varying rates, is often diagnosed late—when clinical signs are already severe. At...
01.07.2025 Research, science & health
Monocyte – un globule blanc qui se différencie en macrophage. Crédit : Université d’Edinbourg.
Discovery of a Macrophage Anomaly in Multiple Sclerosis
Certain patients with multiple sclerosis (MS) can partially regenerate myelin—the protective sheath that surrounds nerve fibers—which is damaged during the evolution of the disease. In studying how immune cells influence this remyelination...
12.19.2024 Research, science & health
See all our news